{"nctId":"NCT00690495","briefTitle":"Use of a Modified Propofol Emulsion in Adults","startDateStruct":{"date":"2008-05"},"conditions":["Anesthesia"],"count":100,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: Propofol"]},{"label":"2","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Propofol 1%"]}],"interventions":[{"name":"Propofol","otherNames":["Modified propofol"]},{"name":"Propofol 1%","otherNames":["Propofol-Lipuro 1%"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male and female adults, age ≥ 18 years and ≤ 80 years\n* Anesthetic risk classified as ASA I-III\n* Patients undergoing elective surgery under general anesthesia\n* Signed informed consent\n\nExclusion Criteria:\n\n* Simultaneous participation in another trial\n* Known or suspected drug abuse\n* Known hypersensitivity to Propofol, other ingredients of the emulsion, or to any other necessary co-medication\n* Not allowed concomitant medication (psychopharmacologic agents, tranquilizers, or centrally active analgesics)\n* Patients taking lipid lowering drugs\n* History of decompensated renal failure\n* History of severe hepatic dysfunction, hepatic cirrhosis\n* Angiographically confirmed CHD (coronary heart disease) or cerebral ischemia\n* History of convulsive disorders\n* Decompensated cardiac insufficiency\n* Hypovolemia\n* Increased intracranial pressure\n* Pregnancy (positive ß-HCG test) and lactation\n* Emergency situation\n* Patient who receives parenteral fat emulsion, e.g. intralipid\n* Patients incapable of giving consent personally\n* Venous access for induction of anesthesia not possible at dorsum of the hand or not dorsal","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Incidence of Expression of Pain During Injection","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]}]},{"type":"SECONDARY","title":"Further Assessment of Injection Pain","description":null,"paramType":null,"dispersionType":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":50},"commonTop":["hypertriglyceridaemia"]}}}